INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -10.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | -37.5% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $16,000 | -20.0% | 2,500 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $20,000 | +17.6% | 2,500 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $17,000 | -15.0% | 2,500 | -13.0% | 0.01% | -22.2% |
| Q4 2016 | $20,000 | -25.9% | 2,875 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $27,000 | 0.0% | 2,875 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $27,000 | +8.0% | 2,875 | 0.0% | 0.01% | +8.3% |
| Q1 2016 | $25,000 | +31.6% | 2,875 | 0.0% | 0.01% | +50.0% |
| Q4 2015 | $19,000 | – | 2,875 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |